Global Health Solutions Retains Objective Capital Partners As Exclusive Advisor for Acquiring Strategic Partnerships
San Diego, CA, May 15, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has announced that it has been retained as exclusive advisor to Global Health Solutions, LLC, to assist the company in exploring strategic partnerships and licensing agreements for its diverse product portfolio and pipeline for wound care, infection, and skin care. The priority focus will be on seeking best in class commercialization partners for the Company’s 510K FDA-cleared Hexagen™ Wound Dressing, which addresses the pressing need for effective solutions in the chronic and advanced wound market(s). Additional assets to be partnered include the FiltreX™ Adhesive Dressing and pipeline assets in dermatology, infection control, biologics, and aesthetics.
“Our partnership with Objective Capital will provide Global Health Solutions with options for driving shareholder value for our novel products through strategic relationships with leading healthcare and pharmaceutical companies,” stated Bradley Burnam, Founder, and CEO of Global Health Solutions. “The strategic initiatives will allow us to focus on our core competencies of developing novel products for unmet medical needs while collaborating with larger strategic partners with greater commercialization resources to maximize value for the innovative products. Objective Capital will help us run a disciplined process and leverage their strong relationships in identifying and selecting partnerships to drive market uptake and adoption for our many assets.”
“We are excited to provide strategic advisory and leadership to Global Health as they navigate different options for growth and capital financing,” stated David H. Crean, Ph.D., Managing Director and head of its life sciences and healthcare practice at Objective Capital Partners. “A powerful business growth strategy that focuses on core competencies and extends the reach and revenue of any company is through creating strategic partnerships. By forming these relationships with other businesses that offer complementary products and services will help both businesses grow and offer innovative products to patients in need of better solutions. The products that Global Health Solutions has created and being developed in the pipeline should be appealing to many strategic companies in the pharmaceutical and device arenas that are looking to grow revenues, earnings, and market share.”
About Global Health Solutions, LLC
Global Health Solutions, LLC, is a concept-to-approval research, development, and regulatory advisory entity focused on novel, best in class products for infection control, skin, and wound care. The company’s proprietary technologies are utilized and endorsed by world-leading healthcare institutions to care for a variety of skin and wound conditions. For more information, including publications and descriptions of our platform and pipeline technologies, visit www.globalhealthrx.com.
About Objective Capital Partners
Objective Capital Partners is a leading M&A investment banking firm whose Principals have collectively engaged in more than 500 successful transactions serving the transaction needs of growth stage and mid-size companies. The executive team has a unique combination of investment banking, private equity, and business ownership experience that enables Objective Capital Partners to provide large enterprise caliber investment banking services to companies. The firm focuses on three areas: middle market M&A and capital raise activities for companies with enterprise values between $10-100 million, healthcare & life sciences and valuation advisory services. The firm’s industry expertise includes software and hardware technology, life sciences, business services, IT services, healthcare services, biotech, consumer products and specialized manufacturing. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. The Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities. Additional information on Objective Capital Partners is available at www.objectivecp.com.
# # #
Objective Capital Partners Contact:
David H. Crean, Ph.D.
Global Health Solutions Contact:
Founder and Chief Executive Officer
This news announcement is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.